Nearly a third of serious adverse drug reactions in patients with chronic kidney disease may be preventable, according to investigators.
51% of nephrology fellows note positive contribution, but time demands have negative impact.
Confusing, ambiguous, and obsolete kidney health terms lead to frustration and distress in patients and caregivers, according researchers.
Many patients with kidney disease are at high risk for severe COVID-19 illness, according to a CDC update.
Clinicians should consider whether a race correction will relieve or exacerbate inequities, according to editorialists.
In a study, nonattendance of a hemodialysis session was significantly associated with higher mortality compared with attendance: 51.9 vs 4.86 per 100 patient-years.
Dialysis decision regret less likely for those who discuss prognosis with doctors, complete living will.
In a study of dialysis patients with new-onset nonvalvular atrial fibrillation, investigators found a nearly 3-fold higher incidence of fatal or intracranial bleeding among patients who took apixaban compared with those who received no treatment.
In a study of dialysis patients in Taiwan, hemodialysis patients had a greater risk for acute myocardial infarction than peritoneal dialysis patients.
In an early case series from a New York hospital, nearly 31% of patients with end-stage kidney disease with COVID-19 died.